Printer Friendly
The Free Library
14,716,650 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Amgen approval.


Amgen Approval: The Food and Drug Administration approved Amgen Inc.'s drug for dialysis dialysis (dīăl`ĭsĭs), in chemistry, transfer of solute (dissolved solids) across a semipermeable membrane. Strictly speaking, dialysis refers only to the transfer of the solute; transfer of the solvent is called osmosis.  patients, Sensipar, which is designed to prevent bone loss in patients with kidney disease Kidney Disease Definition

Kidney disease is a general term for any damage that reduces the functioning of the kidney. Kidney disease is also called renal disease.
. Analysts project that sales of Sensipar could reach $500 million. Thousand Oaks-based Amgen said shipments would begin in the next several weeks.
COPYRIGHT 2004 CBJ, L.P.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Review & preview: March 5-11
Publication:Los Angeles Business Journal
Article Type:Brief Article
Geographic Code:1USA
Date:Mar 15, 2004
Words:50
Previous Article:Gas update.(Review & preview: March 5-11)(gas industry prices)(Brief Article)
Next Article:More reviews.(Wilshire Associates Inc.)(Brief Article)
Topics:



Related Articles
AMGEN'S ANTI-ANEMIA DRUG GETS BOOST.(Business)
AMGEN PROFITS SOAR BUT REST OF YEAR IS IFFY.(Business)(Statistical Data Included)
Amgen at 52-week high on solid earnings, test results. (Corporate Focus).(Amgen Inc.)(related article: Summary)
Amgen sales.(Review & preview: December 12-18)(Brief Article)
CAMBRIDGE ANTIBODY TECHNOLOGY/AMGEN RESTRUCTURE AGREEMENT.
JOURNAL CITES AMGEN DRUG SENSIPAR TREATS DIALYSIS EFFECTS.(Business)
Amgen falls Ill from Medicare payment shifts.
Biotech buy.(THE LABJ Online Journal)(Brief article)
Quick FDA approval gives Amgen drug competitive edge.(HEALTH CARE & BIOTECH)(Food and Drug Administration)(Brief article)
Amgen data debate.(HEALTH CARE & BIOTECH)

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles